bioRxivPharmacology & ToxicologyPreprint
Subcutaneous and orally self-administered high-dose carprofen in male and female mice: pharmacokinetics, tolerability and impact on cage-side pain indicators
A. Glasenapp, J. P. Bankstahl, H. Baehre, S. Glage, M. Bankstahl
Abstract
Surgical interventions in mice are prerequisite in various research fields and require appropriate pain relief, not only to ensure animal welfare but also to avoid influence of pain on research findings. Carprofen is a non-steroidal anti-inflammatory drug that is commonly used as an analgesic for interventions inducing mild to moderate pain in animals. Despite its frequent use also in laboratory rodents, data on pharmacokinetics and side effects, and on its potential impact on behavioral pain indicators are rare. This study aimed to determine pharmacokinetic and tolerability profiles of high dose carprofen in male and female C57Bl/6J mice, administered via single subcutaneous injection (s.c.) and oral self-administration per drinking water (d.w.). Plasma concentrations of carprofen were measured at various time points, and side effects were evaluated using a modified Irwin test protocol, hematology and histopathology. Additionally, potential effects on behavioral pain indicators commonly used to assess post-surgical pain, such as the mouse grimace scale, wheel running activity, burrowing, nesting and grooming behavior were investigated. Quantification of carprofen in plasma revealed maximum plasma concentrations of 133.4 {+/-} 11.3 {micro}g/ml after 1 hour and an elimination half-life of 8.52 hour after single s.c. injection of 20 mg/kg carprofen. Oral self-administration of carprofen (25 mg/kg/24 h) resulted in a steady-state < 24 hours over 5 days after treatment start with plasma levels of around 60 {micro}g/ml. The carprofen-medicated water was highly accepted, and increased d.w. intake was observed in the first 24 hours after exposure for both sexes (p < 0.0001). Irwin test detected only minor side effects, and hematology and histopathology where without pathological findings that could be attributed to carprofen treatment. Except for a decrease of 49-70 % in wheel running activity in male mice, behavioral pain indicators were only very mildly affected. This study determined carprofen plasma levels in mice lying well above an estimated therapeutic concentration for both routes of administration. Carprofen was well tolerated at recommended high doses and may provide sufficient analgesia for minor interventions as well as be applied as a tolerable component in multimodal analgesic regimens.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Metabolic Cage Analysis of Surgically Catheterized C57Bl/6J Mice (Mus musculus) Treated with Carprofen and Sustained-release Buprenorphine
Jui Rose Tu, Marissa Saenz, … Patrick T. Fueger·Journal of the American Association for Laboratory Animal SciencePeer-reviewed·Nov 1, 2025
- Evaluating analgesic efficacy and administration route following craniotomy in mice using the grimace scale
Chulmin Cho, Vassilia Michailidis, … Loren J. Martin·Scientific ReportsPeer-reviewed·Jan 23, 2019
- Pharmacokinetics of Sustained-Release Buprenorphine and Extended-Release Buprenorphine in Mice with Surgical Catheterization
M. Saenz, E. A. Bloom-Saldana, … J. B. Finlay·bioRxiv·Mar 14, 2022
- Escalation of intravenous fentanyl self-administration and assessment of withdrawal behavior in male and female mice
Yueyi Chen, Tiange Xiao, Adam Kimbrough·PsychopharmacologyPeer-reviewed·Dec 27, 2024
- The effects of chronic neuropathic pain on the self-administration of highly potent MOR agonist, fentanyl
Gwendolyn E. Burgess, John R. Traynor, Emily M. Jutkiewicz·bioRxiv·Nov 19, 2024
- Ethological profiling of pain and analgesia in a mouse model of complex regional pain syndrome.
Gabriella P. B. Muwanga, Amanda Y. Pang, … Vivianne L. Tawfik·bioRxiv·Mar 28, 2025